Ovagen is a hepatotropic bioregulator peptide that targets liver parenchymal tissue and supports gastrointestinal mucosal health. Its short amino-acid sequences promote hepatocyte renewal, bile-acid cycling, and the liver's phase-I/II detoxification capacity.
Ovagen is a precision-engineered bioregulator peptide that selectively targets hepatic tissue through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within hepatic tissue cells, Ovagen helps normalise hepatocyte regeneration and bile-acid metabolism—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for hepatic tissue maintenance, making it a fundamentally different approach from conventional supplementation.